Suchergebnisse - Matthias Pinter

The impact of thyroid hormones on patients with hepatocellular carcinoma. von Matthias Pinter, Lukas Haupt, Florian Hucke, Simona Bota, Theresa Bucsics, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart

Volltext

Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients. von Lorenz Balcar, David Bauer, Katharina Pomej, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Matthias Pinter

Volltext

Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion von Lorenz Balcar, Arpad Mrekva, Bernhard Scheiner, Katharina Pomej, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Dietmar Tamandl, Matthias Pinter

Volltext

Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton von Mahzeiar Samadaei, Matthias Pinter, Daniel Senfter, Sibylle Madlener, Nataliya Rohr-Udilova, Dominika Iwan, Karolina Kamińska, Elżbieta Wojaczyńska, Jacek Wojaczyński, Andrzej Kochel

Volltext

EASL position paper on palliative care in advanced chronic liver disease von Sumita Verma, Matthias Pinter, Lucia Macken, Patrizia Künzler-Heule, Lise Lotte Gluud, Bart Takkenberg, Rui Nunes, Liana Gheorghe, Wendy Prentice, Ben Hudson

Volltext

Optimizing Imaging Parameters for Assessment of Hepatocellular Carcinoma Using Photon-Counting Detector Computed Tomography—Impact of Reconstruction Kernel and Slice Thickness von Anna Szelenyi, Philipp Stelzer, Christian Wassipaul, Jakob Kittinger, Andreas Strassl, Victor Schmidbauer, Martin Luther Watzenböck, Florian Lindenlaub, Michael Arnoldner, Michael Weber, Matthias Pinter, Ruxandra-Iulia Milos, Dietmar Tamandl

Volltext

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD von Lorenz Balcar, Benedikt Simbrunner, Rafael Paternostro, Mathias Jachs, Lukas Hartl, Georg Semmler, Benedikt Silvester Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Ton Lisman, Michael Trauner, Peter Quehenberger, Thomas Reiberger, Bernhard Scheiner, Mattias Mandorfer

Volltext

Non-invasive tests to guide hepatocellular carcinoma surveillance von Jan Embacher, Katharina Remih, Carolin Victoria Schneider, Mathias Jachs, Lorenz Balcar, Paul Thöne, Christian Sebesta, Nina Dominik, Georg Kramer, Benedikt Silvester Hofer, Lukas Hartl, Benedikt Simbrunner, Bernhard Scheiner, Matthias Pinter, Michael Trauner, Thomas Reiberger, Pavel Strnad, Georg Semmler, Mattias Mandorfer

Volltext

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma von David J. Pinato, Xiaoxue Li, Pallavi Mishra-Kalyani, Antonio D’Alessio, Claudia A.M. Fulgenzi, Bernhard Scheiner, Matthias Pinter, Guo Wei, Julie Schneider, Donna R. Rivera, Richard Pazdur, Marc R. Theoret, Sandra Casak, Steven Lemery, Lola Fashoyin-Aje, Alessio Cortellini, Lorraine Pelosof

Volltext

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events von Najib Ben Khaled, Marie Möller, Leonie S. Jochheim, Catherine Leyh, Ursula Ehmer, Katrin Böttcher, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Alexander Weich, Hans Benno Leicht, Valentina Zarka, Liangtao Ye, Julia Schneider, Ignazio Piseddu, Osman Öcal, Monika Rau, Friedrich Sinner, Marino Venerito, Simon Johannes Gairing, Friedrich Förster, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter

Volltext

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma von Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, Maria Papp, Nikolaos K. Gatselis, Kalliopi Zachou, Matthias Pinter, Bernhard Scheiner, Arndt Vogel, Martha M. Kirstein, Fabian Finkelmeier, Oliver Waidmann, Arndt Weinmann, Piotr Milkiewicz, Douglas Thorburn, Neil Halliday, Ana Lleo, Samuel Huber, George N. Dalekos, Ansgar W. Lohse, Henning Wege, Johann von Felden, Kornelius Schulze

Volltext

Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence von Giulia Francesca Manfredi, Claudia Angela Maria Fulgenzi, Ciro Celsa, Bernardo Stefanini, Antonio D'Alessio, Matthias Pinter, Bernhard Scheiner, Nichola Awosika, Leonardo Brunetti, Pasquale Lombardi, Charles Latchford, Pei-Chang Lee, Yi-Hsiang Huang, Chun-Yen Lin, Andrea Dalbeni, Arndt Vogel, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Hong Jae Chon, Giuseppe Cabibbo, Fabio Piscaglia, Calogero Cammà, Anjana Pillai, Mario Pirisi, Amit G. Singal, David J. Pinato

Volltext

Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCC von Najib Ben Khaled, Raphael Mohr, Leonie S. Jochheim, Valentina Zarka, Monika Karin, Fabian Artusa, Julia M. Schütte, Vera Himmelsbach, Ursula Ehmer, Katrin Böttcher, Friedrich Foerster, Simon Johannes Gairing, Paula Bark, Alexander Weich, Ignazio Piseddu, Monika Rau, Bernhard Scheiner, Lorenz Balcar, Marino Venerito, Philipp Heumann, Arne Kandulski, Catherine Leyh, Christoph Roderburg, Tom Lüdde, Matthias Pinter, Julia Mayerle, Jens U. Marquardt, Fabian Finkelmeier, Enrico N. De Toni, Andreas Geier, Florian P. Reiter

Volltext

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab von Lorenz Kocheise, Jan Kempski, Yunhe Tang, Lorenz Balcar, Victoria Berger, Miriam Tomczak, Joao Gorgulho, Ramsha Masood, Franziska Giehren, Constantin Schmidt, Jan P. Sutter, Thorben W. Fruendt, Francesca Pagani, Sophie Wulf, Julian Kött, Saskia Domanig, Anastasios Giannou, Tanja Bedke, Jöran Lücke, Tao Zhang, Siwen Zhang, Andres Machicote, Ansgar W. Lohse, Marianna Alunni-Fabbroni, Jens Ricke, Najib Ben Khaled, Matthias Pinter, Bernhard Scheiner, Samuel Huber, Johann von Felden, Ignazio Piseddu, Kornelius Schulze

Volltext

Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study von Yoon Jun Kim, Philippe Merle, Richard S. Finn, Masatoshi Kudo, Heinz-Josef Klümpen, Ho Yeong Lim, Masafumi Ikeda, Alessandro Granito, Gianluca Masi, René Gerolami, Sung Bum Cho, Chih-Hung Hsu, Yi-Hsiang Huang, Long-Bin Jeng, Do Young Kim, Shi-Ming Lin, Matthias Pinter, Guoliang Shao, Naoya Kato, Masayuki Kurosaki, Kazushi Numata, Kung-Kai Kuo, Yilei Mao, Yih-Jyh Lin, Kangshun Zhu, Philip Twumasi-Ankrah, Javeed Khan, Maria Awan, Kirhan Ozgurdal, Shukui Qin

Volltext

Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity von Ignazio Piseddu, Leonie S. Jochheim, Katrin Boettcher, Bernhard Scheiner, Friedrich Sinner, Simon Johannes Gairing, Matthias Thaler, Stefan Enssle, Monika Karin, Valentina Zarka, Alexander Philipp, Andreas Thalmeier, Jan Gaertig, Lorenz Balcar, Julia Martina Schütte, Julia S. Schneider, Katarina Ondrejkova, Monika Rau, Alexander Weich, David Anz, Karin Berger, Christian Schulz, Christian M. Lange, Osman Öcal, Marianna Alunni-Fabbroni, Jens Ricke, Ursula Ehmer, Marino Venerito, Friedrich Foerster, Matthias Pinter, Andreas Geier, Julia Mayerle, Enrico N. De Toni, Florian P. Reiter, Najib Ben Khaled

Volltext

Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study von Pasquale Lombardi, Jung Sun Kim, Giulia F. Manfredi, Ciro Celsa, Claudia A.M. Fulgenzi, Antonio D’Alessio, Bernardo Stefanini, Niraj C. Doshi, Emily Warmington, Thomas U. Marron, Matthias Pinter, Bernhard Scheiner, Beodeul Kang, Ho Yeong Lim, Wei-Fan Hsu, Brooke Wietharn, Marianna Silletta, Alessandro Parisi, Chun-Yen Lin, Andrea Dalbeni, Gianluca Masi, Martin Schönlein, Johann von Felden, Fabio Piscaglia, Peter R. Galle, Masatoshi Kudo, Tiziana Pressiani, Lorenza Rimassa, Mario Pirisi, Giuseppe Cabibbo, Hong Jae Chon, David J. Pinato

Volltext

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab von Meng Wu, Claudia A.M. Fulgenzi, Antonio D’Alessio, Alessio Cortellini, Ciro Celsa, Giulia F. Manfredi, Bernardo Stefanini, Y. Linda Wu, Yi-Hsiang Huang, Anwaar Saeed, Angelo Pirozzi, Tiziana Pressiani, Lorenza Rimassa, Martin Schoenlein, Kornelius Schulze, Johann von Felden, Yehia Mohamed, Ahmed O. Kaseb, Arndt Vogel, Natascha Roehlen, Marianna Silletta, Naoshi Nishida, Masatoshi Kudo, Caterina Vivaldi, Lorenz Balcar, Bernhard Scheiner, Matthias Pinter, Amit G. Singal, Joshua Glover, Susanna Ulahannan, Fredrich Foerster, Arndt Weinmann, Peter R. Galle, Neehar D. Parikh, Wei-Fan Hsu, Alessandro Parisi, Hong Jae Chon, David J. Pinato, Celina Ang

Volltext

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with ate... von Bertram Bengsch, Michael Trauner, Adel Samson, Matthias Pinter, Bernhard Scheiner, Markus Peck-Radosavljevic, David J Pinato, Lorenza Rimassa, Hong Jae Chon, Francesco A Mauri, Teresa Marafioti, Ciro Celsa, Giuseppe Cabibbo, Francesco Vasuri, Gwangil Kim, Carolin Lackner, Robert D Goldin, Mathias Heikenwalder, Fabian Finkelmeier, Fabio Piscaglia, Jaekyung Cheon, Antonio D’Alessio, Claudia A M Fulgenzi, Mohammad Rahbari, Pasquale Lombardi, Rudolf Stauber, Aria Torkpour, Lorenz Balcar, Luca Di Tommaso, Masoud Tafavvoghi, Oleksandr Petrenko, Katharina Pomej, Vera Himmelsbach, Maryam Barsch, Anja Krall, Florian Hucke, Monica Bernasconi, Bernardo Stefanini, Behrang Mozayani, Lill-Tove Rasmussen Busund, Mehrdad Rakaee

Volltext

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study von Ciro Celsa, Tiziana Pressiani, Naoshi Nishida, Shadi Mohamad Chamseddine, Ashwini Arvind, Michael Li, Marta Fortuny, Najib Ben Khaled, Massimo Iavarone, Hidenori Toyoda, Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Susanna Ulahannan, Haripriya Andanamala, Bernhard Scheiner, Matthias Pinter, Elena Orlandi, Claudia A.M. Fulgenzi, Giulia F. Manfredi, Pasquale Lombardi, Antonio D’Alessio, Bernardo Stefanini, Rosanna Villani, Francesca Romana Ponziani, Leonardo Stella, Ornella Carminati, Angela Dalia Ricci, Melina Gonzalez, Alba Sparacino, Gabriele Di Maria, Marco Vaccaro, Giuseppe Cabibbo, Calogero Cammà, Maria Reig, Robin K. Kelley, Amit G. Singal, Ahmed O. Kaseb, Masatoshi Kudo, Lorenza Rimassa, David James Pinato

Volltext